Pathophysiology of hepatic encephalopathy: a new look at GABA from the molecular standpoint (Q35956353)

11 August 2017

1 reference

title

Pathophysiology of hepatic encephalopathy: a new look at GABA from the molecular standpoint (English)

1 reference

11 August 2017

1 reference

hepatic encephalopathy

1 reference

2

Roger F Butterworth

1 reference

11 August 2017

Samir Ahboucha

1

1 reference

11 August 2017

1 December 2004

1 reference

11 August 2017

Metabolic Brain Disease

1 reference

11 August 2017

19

1 reference

11 August 2017

3-4

1 reference

11 August 2017

331-343

1 reference

https://scigraph.springernature.com/pub.10.1023/b:mebr.0000043979.58915.41

11 August 2017

0 references

cites work

Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy

1 reference

12 December 2020

Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain

1 reference

12 December 2020

Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission

1 reference

12 December 2020

Hepatic encephalopathy: lack of changes of gamma-aminobutyric acid content in plasma and cerebrospinal fluid.

1 reference

12 December 2020

Sleep disorders and anxiety: biochemical antecedents and pharmacological consequences

1 reference

12 December 2020

Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy.

1 reference

12 December 2020

Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties

1 reference

12 December 2020

Normal coupling of brain benzodiazepine and neurosteroid modulatory sites on the GABA-A receptor complex in human hepatic encephalopathy

1 reference

12 December 2020

Roles of neuroactive amino acids in ammonia neurotoxicity

1 reference

12 December 2020

Plasma GABA, GABA-like activity and the brain GABA-benzodiazepine receptor complex in rats with chronic hepatic encephalopathy

1 reference

12 December 2020

Pharmacokinetics of benzodiazepine antagonist Ro 15-1788 in cirrhotic patients with moderate or severe liver dysfunction

1 reference

12 December 2020

Affinities and densities of high-affinity [3H]muscimol (GABA-A) binding sites and of central benzodiazepine receptors are unchanged in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.

1 reference

12 December 2020

"Endogenous" benzodiazepine activity in body fluids of patients with hepatic encephalopathy

1 reference

12 December 2020

Supersensitivity of Benzodiazepine Receptors in Hepatic Encephalopathy Due to Fulminant Hepatic Failure in the Rat: Reversal by a Benzodiazepine Antagonist

1 reference

12 December 2020

An update on GABAA receptors

1 reference

12 December 2020

The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor.

1 reference

12 December 2020

Cerebral uptake of benzodiazepine measured by positron emission tomography in hepatic encephalopathy

1 reference

12 December 2020

Increased brain uptake of gamma-aminobutyric acid in a rabbit model of hepatic encephalopathy.

1 reference

12 December 2020

Selective alterations of extracellular brain amino acids in relation to function in experimental portal-systemic encephalopathy: results of an in vivo microdialysis study

1 reference

12 December 2020

Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy

1 reference

12 December 2020

Structure-activity relationships for steroid interaction with the gamma-aminobutyric acidA receptor complex

1 reference

12 December 2020

Autoradiographic analysis of GABA-benzodiazepine receptors in an animal model of acute hepatic encephalopathy

1 reference

12 December 2020

1 reference

12 December 2020

Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis

1 reference

12 December 2020

Selective increase of brain lactate synthesis in experimental acute liver failure: results of a [H-C] nuclear magnetic resonance study

1 reference

12 December 2020

Ammonia, the GABA neurotransmitter system, and hepatic encephalopathy

1 reference

12 December 2020

GABA(A) receptor function and pharmacology in epilepsy and status epilepticus.

1 reference

12 December 2020

Reversal of hepatic coma by benzodiazepine antagonist (Ro 15-1788)

1 reference

12 December 2020

GABA and glutamate receptors as therapeutic targets in neurodegenerative disorders

1 reference

12 December 2020

Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomised, placebo controlled multicentre study

1 reference

12 December 2020

Improvement of hepatic encephalopathy treated with flumazenil

1 reference

12 December 2020

Extra- and intracellular amino acids in the hippocampus during development of hepatic encephalopathy.

1 reference

12 December 2020

Amino acid neurotransmitter receptor changes in cerebral cortex in alcoholism: effect of cirrhosis of the liver

1 reference

12 December 2020

Cerebral aminoacids in portal-systemic encephalopathy: lack of evidence for altered gamma-aminobutyric acid (GABA) function.

1 reference

12 December 2020

The involvement of ammonia with the mechanisms that enhance GABA-ergic neurotransmission in hepatic failure

1 reference

12 December 2020

Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy.

1 reference

12 December 2020

Amino acid changes in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.

1 reference

12 December 2020

GABAergic deafferentation hypothesis of brain aging and Alzheimer's disease revisited

1 reference

12 December 2020

Regional Distribution and Kinetics of Three Sites on the GABAA Receptor: Lack of Effect of Portacaval Shunting

1 reference

12 December 2020

Plasma and CSF benzodiazepine receptor ligand concentrations in cirrhotic patients with hepatic encephalopathy: relationship to severity of encephalopathy and to pharmaceutical benzodiazepine intake.

1 reference

12 December 2020

Metabolism and brain uptake of gamma-aminobutyric acid in galactosamine-induced hepatic encephalopathy in rats.

1 reference

12 December 2020

Activities of neuronal and astrocytic marker enzymes in autopsied brain tissue from patients with hepatic encephalopathy

1 reference

12 December 2020

Flumazenil and hepatic encephalopathy

1 reference

12 December 2020

The peripheral benzodiazepine receptor and neurosteroids in hepatic encephalopathy.

1 reference

12 December 2020

Flumazenil therapy for hepatic encephalopathy. A double-blind cross over study

1 reference

12 December 2020

A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: More support for a continuum hypothesis of ?functional? psychosis

1 reference

12 December 2020

Pregnenolone-sulfate: an endogenous antagonist of the gamma-aminobutyric acid receptor complex in brain?

1 reference

12 December 2020

Increased brain concentrations of endogenous (non-benzodiazepine) GABA-A receptor ligands in human hepatic encephalopathy

1 reference

12 December 2020

Hepatic encephalopathy in cirrhotic and portacaval shunted dogs: lack of changes in brain GABA uptake, brain GABA levels, brain glutamic acid decarboxylase activity and brain postsynaptic GABA receptors

1 reference

12 December 2020

Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure

1 reference

12 December 2020

Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome.

1 reference

12 December 2020

Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.

1 reference

12 December 2020

10.1023/B:MEBR.0000043979.58915.41

Identifiers

DOI

1 reference

PubMed ID

15554425

Dimensions Publication ID

11 August 2017

0 references

1 reference

PubMed ID

15554425